561 related articles for article (PubMed ID: 25460016)
21. Two mesalazine regimens in the prevention of the post-operative recurrence of Crohn's disease: a pragmatic, double-blind, randomized controlled trial.
Caprilli R; Cottone M; Tonelli F; Sturniolo G; Castiglione F; Annese V; Papi C; Viscido A; Cammà C; Corrao G; Latella G
Aliment Pharmacol Ther; 2003 Feb; 17(4):517-23. PubMed ID: 12622760
[TBL] [Abstract][Full Text] [Related]
22. The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis.
Sood A; Midha V; Makharia GK; Ahuja V; Singal D; Goswami P; Tandon RK
Clin Gastroenterol Hepatol; 2009 Nov; 7(11):1202-9, 1209.e1. PubMed ID: 19631292
[TBL] [Abstract][Full Text] [Related]
23. Early post-operative endoscopic recurrence in Crohn's disease patients: data from an Italian Group for the study of inflammatory bowel disease (IG-IBD) study on a large prospective multicenter cohort.
Orlando A; Mocciaro F; Renna S; Scimeca D; Rispo A; Lia Scribano M; Testa A; Aratari A; Bossa F; Tambasco R; Angelucci E; Onali S; Cappello M; Fries W; D'Incà R; Martinato M; Castiglione F; Papi C; Annese V; Gionchetti P; Rizzello F; Vernia P; Biancone L; Kohn A; Cottone M
J Crohns Colitis; 2014 Oct; 8(10):1217-21. PubMed ID: 24630485
[TBL] [Abstract][Full Text] [Related]
24. Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn's disease after surgery.
Wright EK; Kamm MA; De Cruz P; Hamilton AL; Ritchie KJ; Krejany EO; Leach S; Gorelik A; Liew D; Prideaux L; Lawrance IC; Andrews JM; Bampton PA; Jakobovits SL; Florin TH; Gibson PR; Debinski H; Macrae FA; Samuel D; Kronborg I; Radford-Smith G; Selby W; Johnston MJ; Woods R; Elliott PR; Bell SJ; Brown SJ; Connell WR; Day AS; Desmond PV; Gearry RB
Gastroenterology; 2015 May; 148(5):938-947.e1. PubMed ID: 25620670
[TBL] [Abstract][Full Text] [Related]
25. Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study.
Tursi A; Brandimarte G; Papa A; Giglio A; Elisei W; Giorgetti GM; Forti G; Morini S; Hassan C; Pistoia MA; Modeo ME; Rodino' S; D'Amico T; Sebkova L; Sacca' N; Di Giulio E; Luzza F; Imeneo M; Larussa T; Di Rosa S; Annese V; Danese S; Gasbarrini A
Am J Gastroenterol; 2010 Oct; 105(10):2218-27. PubMed ID: 20517305
[TBL] [Abstract][Full Text] [Related]
26. High-Dose Vitamin D Does Not Prevent Postoperative Recurrence of Crohn's Disease in a Randomized Placebo-Controlled Trial.
de Bruyn JR; Bossuyt P; Ferrante M; West RL; Dijkstra G; Witteman BJ; Wildenberg M; Hoentjen F; Franchimont D; Clasquin E; van der Bilt JD; Tollens T; Bemelman WA; D'Hoore A; Duijvestein M; D'Haens GR;
Clin Gastroenterol Hepatol; 2021 Aug; 19(8):1573-1582.e5. PubMed ID: 32461138
[TBL] [Abstract][Full Text] [Related]
27. Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum.
Rutgeerts P; Goboes K; Peeters M; Hiele M; Penninckx F; Aerts R; Kerremans R; Vantrappen G
Lancet; 1991 Sep; 338(8770):771-4. PubMed ID: 1681159
[TBL] [Abstract][Full Text] [Related]
28. Differential risk of disease progression between isolated anastomotic ulcers and mild ileal recurrence after ileocolonic resection in patients with Crohn's disease.
Ollech JE; Aharoni-Golan M; Weisshof R; Normatov I; Sapp AR; Kalakonda A; Israel A; Glick LR; Karrison T; Dalal SR; Sakuraba A; Cohen RD; Rubin DT; Pekow J
Gastrointest Endosc; 2019 Aug; 90(2):269-275. PubMed ID: 30738034
[TBL] [Abstract][Full Text] [Related]
29. Impact of infliximab therapy after early endoscopic recurrence following ileocolonic resection of Crohn's disease: a prospective pilot study.
Yamamoto T; Umegae S; Matsumoto K
Inflamm Bowel Dis; 2009 Oct; 15(10):1460-6. PubMed ID: 19266566
[TBL] [Abstract][Full Text] [Related]
30. High-dose probiotics for the treatment of active pouchitis.
Gionchetti P; Rizzello F; Morselli C; Poggioli G; Tambasco R; Calabrese C; Brigidi P; Vitali B; Straforini G; Campieri M
Dis Colon Rectum; 2007 Dec; 50(12):2075-82; discussion 2082-4. PubMed ID: 17934776
[TBL] [Abstract][Full Text] [Related]
31. Early azathioprine therapy is no more effective than placebo for newly diagnosed Crohn's disease.
Panés J; López-Sanromán A; Bermejo F; García-Sánchez V; Esteve M; Torres Y; Domènech E; Piqueras M; Gomez-García M; Gutiérrez A; Taxonera C; Sans M;
Gastroenterology; 2013 Oct; 145(4):766-74.e1. PubMed ID: 23770132
[TBL] [Abstract][Full Text] [Related]
32. Infliximab prevents Crohn's disease recurrence after ileal resection.
Regueiro M; Schraut W; Baidoo L; Kip KE; Sepulveda AR; Pesci M; Harrison J; Plevy SE
Gastroenterology; 2009 Feb; 136(2):441-50.e1; quiz 716. PubMed ID: 19109962
[TBL] [Abstract][Full Text] [Related]
33. Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn's disease.
Benjamin JL; Hedin CR; Koutsoumpas A; Ng SC; McCarthy NE; Hart AL; Kamm MA; Sanderson JD; Knight SC; Forbes A; Stagg AJ; Whelan K; Lindsay JO
Gut; 2011 Jul; 60(7):923-9. PubMed ID: 21262918
[TBL] [Abstract][Full Text] [Related]
34. Endoscopic lesions in Crohn's disease early after ileocecal resection.
Tytgat GN; Mulder CJ; Brummelkamp WH
Endoscopy; 1988 Sep; 20(5):260-2. PubMed ID: 3168939
[TBL] [Abstract][Full Text] [Related]
35. [Problems related to postoperative clinical relapse and endoscopic recurrence in Crohn's disease].
Renna S; Orlando A; Orlando R; Cottone M
Recenti Prog Med; 2009 Oct; 100(10):469-78. PubMed ID: 20030170
[TBL] [Abstract][Full Text] [Related]
36. [Azathioprine and 5-ASA in the prevention of postoperative recurrence of Crohn's disease].
Nos P; Hinojosa J; Aguilera V; Molés JR; Pastor M; Ponce J; Berenguer J
Gastroenterol Hepatol; 2000 Oct; 23(8):374-8. PubMed ID: 11227650
[TBL] [Abstract][Full Text] [Related]
37. Systematic versus Endoscopy-driven Treatment with Azathioprine to Prevent Postoperative Ileal Crohn's Disease Recurrence.
Ferrante M; Papamichael K; Duricova D; D'Haens G; Vermeire S; Archavlis E; Rutgeerts P; Bortlik M; Mantzaris G; Van Assche G;
J Crohns Colitis; 2015 Aug; 9(8):617-24. PubMed ID: 25926532
[TBL] [Abstract][Full Text] [Related]
38. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial.
Gionchetti P; Rizzello F; Venturi A; Brigidi P; Matteuzzi D; Bazzocchi G; Poggioli G; Miglioli M; Campieri M
Gastroenterology; 2000 Aug; 119(2):305-9. PubMed ID: 10930365
[TBL] [Abstract][Full Text] [Related]
39. Structural robustness of the gut mucosal microbiota is associated with Crohn's disease remission after surgery.
Mondot S; Lepage P; Seksik P; Allez M; Tréton X; Bouhnik Y; Colombel JF; Leclerc M; Pochart P; Doré J; Marteau P;
Gut; 2016 Jun; 65(6):954-62. PubMed ID: 26628508
[TBL] [Abstract][Full Text] [Related]
40. Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial.
Rutgeerts P; Van Assche G; Vermeire S; D'Haens G; Baert F; Noman M; Aerden I; De Hertogh G; Geboes K; Hiele M; D'Hoore A; Penninckx F
Gastroenterology; 2005 Apr; 128(4):856-61. PubMed ID: 15825069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
